Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
Novartis
Novartis
Takeda
Gamida Cell ltd
Novartis
Janssen Research & Development, LLC
Incyte Corporation
Novartis
Takeda
Constellation Pharmaceuticals
Janssen Research & Development, LLC
Novartis
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
PharmaEssentia Japan K.K.
Novartis
Shenzhen TargetRx, Inc.
Novartis
Incyte Corporation
Novartis
Celgene
Protagonist Therapeutics, Inc.
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Janssen Research & Development, LLC
American Regent, Inc.
Janssen Research & Development, LLC
Novartis
Blueprint Medicines Corporation
Novartis
Novartis
Fujifilm Pharmaceuticals U.S.A., Inc.
Karyopharm Therapeutics Inc
Aprea Therapeutics
Celgene
Ascentage Pharma Group Inc.
AbbVie
BerGenBio ASA
Stemline Therapeutics, Inc.
Syros Pharmaceuticals
Novartis
PharmaEssentia Japan K.K.
Advice Pharma Group srl
Celgene
Astellas Pharma Inc
Swedish Orphan Biovitrum
Cyclacel Pharmaceuticals, Inc.
Takeda
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.